Plain-English translation of NCT05688969 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
Researchers want to understand how romosozumab works to strengthen bones in women with osteoporosis. This study will take small bone samples from your hip before you start the medication and again a few weeks or months after you begin treatment, so scientists can see exactly how the medication changes your bone at the microscopic level.
While this medication is already approved and prescribed for osteoporosis, doctors don't fully understand the detailed biological changes it causes in bone. This research will help explain how the treatment actually works, which may lead to even better therapies in the future.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have two bone biopsy procedures โ one before starting romosozumab and one after starting treatment. The second biopsy will be performed either 3โ6 weeks after you begin the medication (early group) or 6โ8 months after (late group), and you will be randomly assigned to one of these timeframes. Each biopsy is a minor outpatient procedure where doctors remove a small sample of bone from your hip.
AI-generated summary from trial data ยท Jun 6, 2026 ยท Not medical advice
United States
Sponsor
Massachusetts General Hospital
Enrollment target
~16 participants
Started
June 2023
Primary completion
February 2028
Age range
45 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Mackenzie Jordan
Massachusetts General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.